(Q51372498)

English

Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study.

scientific article published on 3 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

Simon J. Griffin

10

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

12

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

Nicholas J. Wareham

11

object named as

N J Wareham

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

author name string

D R Webb

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

B Srinivasan

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

N Taub

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

S Campbell

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

J Barnett

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

A Farooqi

8

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

J B Echouffo-Tcheugui

9

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

publication date

3 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

54

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

9

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

2237-2246

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

https://scigraph.springernature.com/pub.10.1007/s00125-011-2189-2

0 references

Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

High prevalence of type 2 diabetes in all ethnic groups, including Europeans, in a British inner city: relative poverty, history, inactivity, or 21st century Europe?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Diabetes prevalence in England, 2001--estimates from an epidemiological model

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Representation of South Asian people in randomised clinical trials: analysis of trials' data

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Effect of nateglinide on the incidence of diabetes and cardiovascular events

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Effect of valsartan on the incidence of diabetes and cardiovascular events

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

International physical activity questionnaire: 12-country reliability and validity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Screening for diabetes in general practice: cross sectional population study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Risk factors for early myocardial infarction in South Asians compared with individuals in other countries

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Comparative prevalence of non-insulin-dependent diabetes mellitus in Asian and white Caucasian adults

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2189-2

21 January 2018

Screening for type 2 diabetes: literature review and economic modelling

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638133

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finding diabetics--a method of screening in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638133

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638133

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type 2 diabetes and cardiovascular disease in South Asians

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638133

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638133

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-011-2189-2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21638133

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51372498&oldid=1594792355"